Goldman Sachs’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,507
Closed -$31K 6342
2022
Q3
$31K Sell
5,507
-375
-6% -$4.04K ﹤0.01% 5861
2022
Q2
$52K Sell
5,882
-1,867
-24% -$18.9K ﹤0.01% 6020
2022
Q1
$121K Sell
7,749
-17,751
-70% -$308K ﹤0.01% 6045
2021
Q4
$677K Buy
25,500
+21,553
+546% +$818K ﹤0.01% 5151
2021
Q3
$192K Sell
3,947
-13,982
-78% -$864K ﹤0.01% 5737
2021
Q2
$1.51M Sell
17,929
-168
-0.9% -$14.4K ﹤0.01% 4447
2021
Q1
$1.83M Buy
18,097
+16,720
+1,214% +$1.84M ﹤0.01% 4080
2020
Q4
$139K Buy
1,377
+331
+32% +$22.1K ﹤0.01% 5216
2020
Q3
$48K Buy
+1,046
New +$53.7K ﹤0.01% 5198

Other funds holding AWH

Goldman Sachs's AWH Position: Q4 2022 in Review

Goldman Sachs sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q4 2022, closing a stake of 5,507 shares — an estimated $31K sold.

Goldman Sachs first reported a position in AWH in Q3 2020 and held it in 9 quarters. The position peaked at $1.83M in Q1 2021. 47 funds tracked by Wall St. Rank hold AWH as of Q4 2022.

  • Goldman Sachs reported no remaining Aspira Women's Health Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Goldman Sachs sold 5,507 Aspira Women's Health Inc. Common Stock shares in Q4 2022, an estimated $31K.
  • Goldman Sachs first reported a position in Aspira Women's Health Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • Goldman Sachs's Aspira Women's Health Inc. Common Stock position peaked at $1.83M in Q1 2021.
  • 47 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.